 |
Trimetrexate glucuronate |
|---|---|
| Trade Name | |
| Orphan Indication | Patients with advanced non-small cell carcinoma of the lung |
| USA Market Approval | USA |
| USA Designation Date | 1988-01-13 00:00:00 |
| Sponsor | Medimmune Oncology, Inc.;One MedImmune Way;Gaithersburg, Maryland, 20878 |
